Fundraising Fox
Find your path to Jim
68 people in our graph can introduce you to Jim.
Sign up to see every warm intro you have to Jim
- Paths you didn't know you had: your email and LinkedIn already hold routes to Jim. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EVP, Chief Commercial Officer at Aligos Therapeutics
Intro paths
→
In turn, Jim can intro founders to Aligos Therapeutics's investors below.
Aligos Therapeutics's investors · 5
Co-founders at Aligos Therapeutics
LB
Leonid BeigelmanPresident
LM
Lawrence M. BlattChairman, President & CEO (Co-founder)
Experience
- Aligos TherapeuticsChief Commercial Officercurrent2026 — presentSouth San Franciso
- Geron CorporationSenior Vice President, Sales & Marketing2024 — 2025United States
- Crinetics PharmaceuticalsChief Commercial Officer2022 — 2024San Diego, California, United States
- Arrowhead PharmaceuticalsChief Commercial Officer & Business Development Lead2020 — 2021Pasadena, California
- Coherus BioSciencesSenior Vice President, Marketing & Market Access2016 — 2020San Francisco Bay Area
Skills & more
Change ManagementSales & Marketing Leadership
Languages English · French
From Jim's professional profile.
Frequently asked questions
- Who is Jim Hassard?
- EVP, Chief Commercial Officer at Aligos Therapeutics
- Where does Jim Hassard work?
- Jim Hassard is EVP, Chief Commercial Officer at Aligos Therapeutics.
- Where did Jim Hassard go to school?
- Jim Hassard studied at University of Toronto (B.Sc.(Hons), Pharmacology); Nova Southeastern University (Master of Business Administration (MBA)).
Same school
Also attended University of Toronto765
Ilya SutskeverCo-founder of OpenAI; co-founder & CEO of Safe SuperintelligenceNick FrosstCo-founder of CohereYasmin RazaviInvestor at Spark CapitalImran BashirFounding Partner, Chief Operating Officer at Extreme Venture PartnersKarim GillaniGeneral Partner at Luge CapitalAndrew MiklasGeneral Partner at Y Combinator
+ 759 more
Also attended Nova Southeastern University37
Catherine Pearce, DHSc, MBAAdvisor at CincyTechGanesh PersadVice President & Chief Information Officer at Flare Capital PartnersDayakar PuskoorFounder and Managing Director at Dallas Venture CapitalDavid G. AlexanderVice Chairman and Managing Director at Third Eye CapitalDr. David G. AlexanderVice-Chairman and Managing Director at Third Eye CapitalErin DeeLender Member Board Member at The Mortgage Collaborative
+ 31 more
Shared employers
Also worked at Aligos Therapeutics11
Bridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalJack NielsenManaging Partner at Vivo CapitalCarole NuechterleinHead of Roche Venture Fund at Roche Venture FundMargarita ChavezManaging Director at AbbViePierre RaboissonChief Executive Officer Chief Scientific Officer Co-founder at CoultreonFrançois GonzalvezCo-founder at Coultreon
+ 5 more
Also worked at Geron Corporation9
Joyce BremerInvestor at True VenturesMelissa LezametaAssociate at Epidarex CapitalDaniel BradburyInvestor at BioBritMelya Hughes CrameriPartner at Ventac PartnersNam KimExecutive Officer, Director at KDx DiagnosticsCatherine PriestChief Development Officer at Neurona Therapeutics
+ 3 more
Also worked at Crinetics Pharmaceuticals7
David AllisonManaging Director at Westlake Village BioPartnersMichael WoodExecutives in Residence at GENERAL INCEPTIONJack NielsenManaging Partner at Vivo CapitalStephen F. BetzExecutive Officer at Crinetics Pharmaceuticals, Inc.R. Scott StruthersPresident, Chief Executive Officer and Director at CrineticsTobin SchilkeChief Financial Officer at Crinetics
+ 1 more
